Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Talis Biomedical Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q1 2023
- Shares held
- 11.0M
- −775.4K (−6.6%) vs. Q1 2023
- Total value
- $5.27M
- −$489.8K (−8.5%) vs. Q1 2023
- New holders
- 3
- 4 more added
- Sold out
- 3
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLIS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $26 |
| Q3 2024 | 2 | $460.4K |
| Q2 2024 | 18 | $6.84M |
| Q1 2024 | 18 | $6.93M |
| Q4 2023 | 18 | $5.93M |
| Q3 2023 | 19 | $4.27M |
| Q2 2023 | 22 | $5.27M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 27 | $5.60M |
| Q3 2022 | 29 | $8.59M |
| Q2 2022 | 35 | $12.1M |
| Q1 2022 | 45 | $23.6M |
| Q4 2021 | 47 | $70.2M |
| Q3 2021 | 38 | $119.2M |
| Q2 2021 | 43 | $184.0M |
| Q1 2021 | 45 | $269.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Talis Biomedical Corp; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 150 | $0 | 0.00% | +27+22.0% | Added |
| New England Capital Financial Advisors LLC | 10 | $5 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 26 | $12 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 174 | $84 | 0.00% | +7+4.2% | Added |
| Larson Financial Group LLC | 200 | $96 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 273 | $131 | 0.00% | −254−48.2% | Reduced |
| Advisor Group Holdings, Inc. | 1,564 | $751 | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 10,000 | $4.80K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,476 | $5.03K | 0.00% | +10,476 | New |
| Northern Trust Corp | 27,860 | $13.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 38,876 | $18.7K | 0.00% | +38,876 | New |
| Deutsche Bank AG | 45,294 | $21.7K | 0.00% | −14,826−24.7% | Reduced |
| State Street Corp | 47,436 | $22.8K | 0.00% | −2,100−4.2% | Reduced |
| Two Sigma Securities, LLC | 49,007 | $23.5K | 0.00% | +49,007 | New |
| Renaissance Technologies LLC | 54,900 | $26.0K | 0.00% | +12,400+29.2% | Added |
| Morgan Stanley | 61,857 | $29.7K | 0.00% | +1,000+1.6% | Added |
| BlackRock Inc. | 76,307 | $36.6K | 0.00% | −6,156−7.5% | Reduced |
| Millennium Management LLC | 91,463 | $43.9K | 0.00% | −72,200−44.1% | Reduced |
| Geode Capital Management, LLC | 140,530 | $67.5K | 0.00% | −3,886−2.7% | Reduced |
| Vanguard Group Inc | 466,336 | $223.8K | 0.00% | −5,090−1.1% | Reduced |
| Greenlight Capital Inc | 2,235,783 | $1.07M | 0.05% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 7,624,835 | $3.66M | 0.02% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 0 | $0 | 0.00% | −478,862−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −223,934−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −79,880−100.0% | Sold out |